Clinical Trials

Exact Sciences

IRB
Details
Info
21-021
DETECT-ASCEND 2: Detecting Cancers Earlier Through Elective Plasma-Based CancerSEEK Testing-AScertaining Serial Cancer Patients to Enable New Diagnostic II. The study anticipates enrolling 4500 Stage I-IV cancer patients aged 50+.